Related Experiment Video
Updated: Jun 23, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiovascular risk and management in chronic kidney disease
Diana Rucker1, Marcello Tonelli
1Division of General Internal Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Insights
Chronic kidney disease (CKD) accelerates cardiovascular disease due to traditional and nontraditional risk factors. Optimal management and further research are crucial for this high-risk population.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Chronic kidney disease (CKD) significantly increases cardiovascular disease (CVD) risk.
- Patients with CKD face a high burden of traditional CVD risk factors.
- Nontraditional risk factors like inflammation and mineral metabolism abnormalities exacerbate CVD in CKD.
Purpose of the Study:
- To review the epidemiology of CVD in patients with stage 3-5 CKD.
- To outline relevant cardiovascular risk factors in this population.
- To discuss optimal management strategies and identify research gaps for CVD in CKD.
Main Methods:
- Literature review of epidemiological data on CVD in CKD.
- Analysis of traditional and nontraditional cardiovascular risk factors.
- Discussion of current management practices and therapeutic underuse.
Main Results:
- CKD is strongly linked to accelerated CVD progression.
- Underuse of potentially beneficial therapies is noted in stages 3-4 CKD and dialysis patients.
- A comprehensive understanding of risk factors is essential for effective management.
Conclusions:
- CKD patients require tailored strategies to mitigate cardiovascular risk.
- Further research is needed to optimize CVD prevention and treatment in CKD.
- Addressing both traditional and nontraditional risk factors is key for improving outcomes.
Abstract:
Chronic kidney disease (CKD) is associated with accelerated progression of cardiovascular disease, perhaps because patients with CKD have a high burden of traditional cardiovascular risk factors in addition to a range of nontraditional risk factors such as inflammation and abnormal metabolism of calcium and phosphate. Although the cardiovascular burden of CKD is well documented, potentially beneficial therapies are sometimes underused in patients with stage 3-4 CKD and are rarely studied in patients on dialysis. In this Review, we describe the epidemiology of cardiovascular disease in patients with stage 3-5 CKD (excluding kidney transplant recipients) and outline cardiovascular risk factors that are relevant in this population; we then discuss the implications of this knowledge for the optimal management of cardiovascular risk in this setting. Finally, we highlight opportunities for further research.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care

